C22.1 Código facturable y específico Intrahepatic bile duct carcinoma
ICD-10-CM C22.1 identifies “Intrahepatic bile duct carcinoma” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Inclusion terms1
Cholangiocarcinoma
Excludes 11
malignant neoplasm of hepatic duct (C24.0)
Instrucciones de niveles superiores
C22 · Malignant neoplasm of liver and intrahepatic bile ducts
Excludes 12
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C15-C26 · Malignant neoplasms of digestive organs (C15-C26)
Excludes 11
Kaposi's sarcoma of gastrointestinal sites (C46.4)
Excludes 21
gastrointestinal stromal tumors (C49.A-)
Referencias del índice oficial
Referencias del índice oficial (17)
Adenocarcinoma (3)
- Adenocarcinoma › bile duct typeÍndice de enfermedades
- Adenocarcinoma › bile duct type › liverÍndice de enfermedades
- Adenocarcinoma › bile duct type › unspecified siteÍndice de enfermedades
Cancer (1)
- Cancer › bile duct type liverÍndice de enfermedades
Carcinoma(malignant) (2)
- Carcinoma(malignant) › bile duct › liverÍndice de enfermedades
- Carcinoma(malignant) › bile duct › unspecified siteÍndice de enfermedades
Cholangiocarcinoma (2)
- Cholangiocarcinoma › liverÍndice de enfermedades
- Cholangiocarcinoma › unspecified siteÍndice de enfermedades
Cystadenocarcinoma (1)
- Cystadenocarcinoma › bile ductÍndice de enfermedades
Neoplasm, neoplastic (8)
- Neoplasm, neoplastic › bile or biliary(tract) › canaliculi(biliferi) (intrahepatic)Neoplasias
- Neoplasm, neoplastic › bile or biliary(tract) › canals, interlobularNeoplasias
- Neoplasm, neoplastic › bile or biliary(tract) › duct or passage(common) (cystic) (extrahepatic) › interlobularNeoplasias
- Neoplasm, neoplastic › bile or biliary(tract) › duct or passage(common) (cystic) (extrahepatic) › intrahepaticNeoplasias
- Neoplasm, neoplastic › canaliculi, biliary(biliferi) (intrahepatic)Neoplasias
- Neoplasm, neoplastic › cholangioleNeoplasias
- Neoplasm, neoplastic › gall duct(extrahepatic) › intrahepaticNeoplasias
- Neoplasm, neoplastic › intrahepatic(bile) ductNeoplasias
Referencias desde otros códigos (1)
Excludes 1 · malignant neoplasm of intrahepatic bile duct (C22.1)
Historial
Historial del código
Último cambio registrado · FY2017
ModificadoSin cambios
FY2017
Vigente desde
- Cambios en instrucciones heredadas
Intrahepatic bile duct carcinoma
Código de diagnóstico facturable
CDC/NCHS · FY2017Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Cambios en instrucciones heredadas |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Correspondencias históricas ICD-9 · 2018
Solo correspondencia histórica; no sustituye códigos automáticamente.
- 155.1
Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.